based on the curriculum of the Federal Biotechnology Authority with viral vector systems, transgenic animal models and the European Genetic Engineering Directive as additional areas of focus. This course is

Institute for Experimental Immunology of TWINCORE (Prof. Dr. Ulrich Kalinke) on the development of small animal models for HCV. These models will be used in the future for studies on the pathogenesis of hepatitis

scientific practice” at MHH For students working with laboratory animals: Successful completion of the course “Basics in Laboratory Animal Sciences” After 18 months, you have to successfully pass the in

Further development of mental health care structures in patients with ethyltoxic liver cirrhosis Animal model of alcohol dependence Investigation of the regulation of addiction disorders in post mortem [...] consecutive expression of its derivative, alpha-melanocyte-stimulating hormone, in alcohol dependence in animal models." 2016-2017: IFB-Tx (Integrated Research and Treatment Center Transplantation) project CO

in Bonn (1982-88), and obtained a Diploma in Cell Biology analyzing autophagy in the single cell animal Amoeba proteus. She then trained as a DAAD fellow (German Academic Exchange Service; 1988/89) at [...] Scientist (2005-2010) Sandra Oetjen - MSc Biomedizin, MSc student (2010) Michela Cappucci - MSc Animal Biology & MSc student (2010) Kathrin Rode - Dr. rer. nat., Pre- and Postdoctoral Scientist (2003-2009)

formulations in parallel, significantly enhancing throughput while reducing the number of laboratory animals required, in line with the 3R principles (Replace, Reduce, Refine). Contact: XXXXX Key references:

the treatment of diseases caused by mutations of the contractile proteins. In the accompanying animation, the reactive thiol region (SH1/SH2) in the myosin motor domain, which is a focal point of allosteric

importance for the regulation of developmental processes and tissue homeostasis. Using the mouse as the animal model of choice and a combination of biochemical, molecular genetic and transgenic methods, we analyze

back". For the time being, however, the visitors bid farewell to the evening in good spirits and animated discussions - until next time. The exhibition "Epidemics - Curse of the Past, Threat of the Future"

the logical continuation of the research work. "We are now further testing the Meg3 inhibitor in animal models for efficacy safety in order to reach clinical maturity," explains Professor Thum. For this